Craig Boulton

Title: Craig Boulton: Innovator in S1P Receptor Modulation

Introduction

Craig Boulton is a notable inventor based in Horsham, GB. He has made significant contributions to the field of medicine, particularly in the treatment of multiple sclerosis and other inflammatory disorders. With a total of 2 patents, his work focuses on innovative dosage regimens for S1P receptor modulators.

Latest Patents

Boulton's latest patents include a dosage regimen of an S1P receptor modulator aimed at treating patients suffering from multiple sclerosis. This invention emphasizes the importance of testing patients for a history of infection caused by the varicella zoster virus and ensuring they are vaccinated prior to the administration of the modulator. Another patent also addresses the treatment of patients with inflammatory or autoimmune disorders, specifically detailing a regimen for administering fingolimod or its pharmaceutically acceptable salts at a daily dosage of 0.5 mg.

Career Highlights

Throughout his career, Craig Boulton has worked with prominent companies, including Novartis AG. His expertise in the field has allowed him to develop innovative solutions that enhance patient care and treatment outcomes.

Collaborations

Boulton has collaborated with notable colleagues such as Pascale Burtin and Olivier David. Their combined efforts have contributed to advancements in the understanding and treatment of complex medical conditions.

Conclusion

Craig Boulton's contributions to the field of medicine through his patents and collaborations highlight his commitment to improving patient care. His innovative approaches to S1P receptor modulation continue to influence the treatment landscape for multiple sclerosis and other disorders.